Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Oncotarget, 8, 4, S. 7039-7049
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2016
- Ereignis
-
Veröffentlichung
- (wer)
-
Impact Journals, LLC
- (wann)
-
2016
- Urheber
-
Wolf, Herta
Lapa, Constantin
Ilhan, Harun
Higuchi, Takahiro
Buck, Andreas K.
Lehner, Sebastian
Bartenstein, Peter
Bengel, Frank M.
Schatka, Imke
Muegge, Dirk O.
Papp, László
Zsótér, Norbert
Große-Ophoff, Tobias
Essler, Markus
Bundschuh, Ralph A.
- DOI
-
10.18632/oncotarget.12402
- URN
-
urn:nbn:de:bvb:384-opus4-630901
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:45 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wolf, Herta
- Lapa, Constantin
- Ilhan, Harun
- Higuchi, Takahiro
- Buck, Andreas K.
- Lehner, Sebastian
- Bartenstein, Peter
- Bengel, Frank M.
- Schatka, Imke
- Muegge, Dirk O.
- Papp, László
- Zsótér, Norbert
- Große-Ophoff, Tobias
- Essler, Markus
- Bundschuh, Ralph A.
- Universität Augsburg
- Impact Journals, LLC
Entstanden
- 2016
Ähnliche Objekte (12)
Radionuclide imaging of neurohormonal system of the heart
The next era of renal radionuclide imaging: novel PET radiotracers
Assessment of the left ventricular systolic and diastolic function in rats using electrocardiogram-gated cardiac positron emission tomography
Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation: Functional assessment using in vitro radionuclide uptake assay
Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation: Functional assessment using in vitro radionuclide uptake assay
Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation: functional assessment using in vitro radionuclide uptake assay
Predictive value of FDG-PET in patients with advanced medullary thyroid cancer undergoing vandetanib treatment
SPECT vs. PET in Cardiac Innervation Imaging: Clash of the Titans
Recent paradigm shifts in molecular cardiac imaging: establishing precision cardiology through novel 18F-labeled PET radiotracers
Pre-therapy Somatostatin-Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy
Pre-therapy somatostatin receptor-based heterogeneity predicts overall survival in pancreatic neuroendocrine tumor patients undergoing peptide receptor radionuclide therapy
Exciting opportunities in nuclear medicine imaging and therapy
Radionuclide imaging of neurohormonal system of the heart
The next era of renal radionuclide imaging: novel PET radiotracers
Assessment of the left ventricular systolic and diastolic function in rats using electrocardiogram-gated cardiac positron emission tomography
Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation: Functional assessment using in vitro radionuclide uptake assay
Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation: Functional assessment using in vitro radionuclide uptake assay
Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation: functional assessment using in vitro radionuclide uptake assay
Predictive value of FDG-PET in patients with advanced medullary thyroid cancer undergoing vandetanib treatment
SPECT vs. PET in Cardiac Innervation Imaging: Clash of the Titans
Recent paradigm shifts in molecular cardiac imaging: establishing precision cardiology through novel 18F-labeled PET radiotracers
Pre-therapy Somatostatin-Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy
Pre-therapy somatostatin receptor-based heterogeneity predicts overall survival in pancreatic neuroendocrine tumor patients undergoing peptide receptor radionuclide therapy
Exciting opportunities in nuclear medicine imaging and therapy
Radionuclide imaging of neurohormonal system of the heart
The next era of renal radionuclide imaging: novel PET radiotracers
Assessment of the left ventricular systolic and diastolic function in rats using electrocardiogram-gated cardiac positron emission tomography
Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation: Functional assessment using in vitro radionuclide uptake assay
Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation: Functional assessment using in vitro radionuclide uptake assay
Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation: functional assessment using in vitro radionuclide uptake assay
Predictive value of FDG-PET in patients with advanced medullary thyroid cancer undergoing vandetanib treatment
SPECT vs. PET in Cardiac Innervation Imaging: Clash of the Titans
Recent paradigm shifts in molecular cardiac imaging: establishing precision cardiology through novel 18F-labeled PET radiotracers
Pre-therapy Somatostatin-Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy
Pre-therapy somatostatin receptor-based heterogeneity predicts overall survival in pancreatic neuroendocrine tumor patients undergoing peptide receptor radionuclide therapy